Corrigendum to "Inhibitory effect of Salvia miltiorrhia BGE on matrix metalloproteinase-9 activity and migration of TNF-α-induced human aortic smooth muscle cells" [Vascular Pharmacology 44 (2006) 345-353] (DOI:10.1016/j.vph.2006.01.007);Inhibitory effect of Salvia miltiorrhia BGE on matrix metalloproteinase-9 activity and migration of TNF-α-induced human aortic smooth muscle cells

Vascular Pharmacology

Volumn 44, Issue 5, 2006, Pages 345-353

  Jin, Un Ho ^a   Kang, Sung Koo ^a   Suh, Suk Jong ^a   Hong, Sung Yoo ^b   Park, Sun Dong ^b   Kim, Dong Wook ^c   Chang, Hyeng Wook ^d   Son, Jong Keun ^d   Lee, Seung Ho ^d   Son, Kun Ho ^e   Kim, Cheorl Ho ^a  

^a Sungkyunkwan University   (South Korea)

^b Dongguk University   (South Korea)

^c Mokpo National University   (South Korea)

^d Yeungnam University   (South Korea)

^e Andong National University   (South Korea)

Author keywords

Human aortic smooth muscle cells; Matrix metalloproteinase 9; Migration; Radix Salviae Miltiorrahizae (Salvia miltiorrhiza Bunge); TNF

Indexed keywords

ACETIC ACID ETHYL ESTER; BUTANOL; CHLOROFORM; GELATIN; GELATINASE B; MATRIGEL; SALVIA MILTIORRHIZA EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; MEDICINAL PLANT; NITROBLUE TETRAZOLIUM TEST; PLANT STEM; PRIORITY JOURNAL; PROTEIN DEGRADATION; SALVIA MILTIORRHIZA; SMOOTH MUSCLE FIBER; ZYMOGRAPHY;

EID: 33646547325     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.08.001     Document Type: Erratum

References (58)

1. Bendeck M.P., Irvin C., and Reidy M.A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circulation Research 78 (1996) 38-43
2. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica et Biophysica Acta 1477 (2000) 267-283
3. Chamley-Campbell J., Campbellm G.R., and Ross R. The smooth muscle cells in culture. Physiological Review 59 (1979) 1-61
4. Chang H.M., and But P.P. Pharmacology and Applications of Chinese Material Medica (1986), World Scientific Publication, Singapore
5. Chen Y.L., Yang S.P., Shiao M.S., Chen J.W., and Lin S.J. Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits. Journal of Cellular Biochemistry 83 3 (2001) 484-493
6. Chen Y.H., Lin S.J., Ku H.H., Shiao M.S., Lin F.Y., Chen J.W., and Chen Y.L. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. Journal of Cellular Biochemistry 82 3 (2001) 512-521
7. Cho A., and Reidy M.A. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circulation Research 91 (2002) 845-851
8. Cho A., Graves J., and Reidy M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arteriosclerosis, Thrombosis and Vascular Biology 20 (2000) 2527-2532
9. Chung T.W., Lee Y.C., and Kim C.H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB Journal 18 10 (2004) 1123-1125
10. Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., Kim S.H., Kim J.G., and Kim C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB Journal 18 14 (2004) 1670-1681
11. Demeule M., Brossard M., Page M., Gingras D., and Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochimica et Biophysica Acta 1478 (2000) 51-60
12. Dollery C.M., McEwan J.R., and Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circulation Research 77 (1995) 863-868
13. Fitzgerald M., Hayward I.P., Thomas A.C., Campbell G.R., and Campbell J.H. Matrix metalloproteinases can facilitate the heparanase-induced promotion of phenotypic change in vascular smooth muscle cells. Atherosclerosis 145 (1999) 97-106
14. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Unemori E.N., Lark M.W., Amento E., and Libby P. Cytokine stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circulation Research 75 (1994) 181-189
15. Galis Z.S., Johnson C., Godin D., Magid R., Shipley J.M., Senior R.M., and Ivan E. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circulation Research 91 (2002) 852-859
16. Ha K.T., Kim J.K., Lee Y.C., and Kim C.H. Inhibitory effect of Daesungki-Tang on the invasiveness potential of hepatocellular carcinoma through inhibition of matrix metalloproteinase-2 and -9 activities. Toxicology and Applied Pharmacology 200 1 (2004) 1-6
17. Ha K.T., Lee T.K., Kwak K.H., Kim J.K., Kim D.I., Choi D.Y., and Kim C.H. Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-alpha through inhibition of matrix metalloproteinase-2 and -9 activity. Vascular Pharmacology 41 3 (2004) 83-90
18. Ha K.T., Kim J.K., Kang S.K., Kim D.W., Lee Y.C., Kim H.M., and Kim C.H. Inhibitory effect of Sihoga-Yonggol-Moryo-Tang on matrix metalloproteinase-2 and -9 activities and invasiveness potential of hepatocellular carcinoma. Pharmacological Research 50 3 (2004) 279-285
19. Heber D. Herbs and atherosclerosis. Current Atherosclerosis Reports 3 (2001) 93-96
20. Hsieh M.T., Peng W.H., Wu C.R., and Wang W.H. The ameliorating effects of the cognitive-enhancing Chinese herbs on scopolamine-induced amnesia in rats. Phytotherapy Research 14 (2000) 375-377
21. Huang H.C., Wang H.R., and Hsieh L.M. Antiproliferative effect of baicalein, a flavonoid from a Chinese herb, on vascular smooth muscle cell. European Journal of Pharmacology 251 (1994) 91-93
22. Hung H.H., Chen Y.L., Lin S.J., Yang S.P., Shih C.C., Shiao M.S., and Chang C.H. A salvianolic acid B-rich fraction of Salvia miltiorrhiza induces neointimal cell apoptosis in rabbit angioplasty model. Histology and Histopathology 16 1 (2001) 175-183
23. Ji X., Tan B.K., Zhu Y.C., Linz W., and Zhu Y.Z. Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats. Life Sciences 73 11 (2003) 1413-1426
24. Jung, H.S., 2002. Radix Salviae Miltiorrahizae extract (Salvia miltiorrhia BGE)(SME) protects rat pheochromocytoma cells against hydrogen peroxide-induced injury. Department of Oriental Medicine, Graduate School of Dongguk University, Kyungju, Korea. Thesis for Master's degree.
25. Kaegi E. Unconventional therapies for cancer: 2. Green tea. The task force on alternative therapies of the Canadian breast cancer research initiative. Canadian Medical Association Journal 158 (1998) 1033-1035
26. Kenagy R.D., Vergel S., Mattsson E., Bendeck M., Reidy M.A., and Clowes A.W. The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration. Arteriosclerosis, Thrombosis and Vascular Biology 16 (1996) 1373-1382
27. Kim D.W., Chung H.J., Nose K., Maruyama I., and Tani T. Preventive effects of a traditional Chinese formulation, Chaihu-jia-Longgu-Muli-tang, on intimal thickening of carotid artery injured by balloon endothelial denudation in rats. Journal of Pharmacy and Pharmacology 54 (2002) 571-575
28. Kim B.J., Kim Y.K., Park W.H., Ko J.H., Lee Y.C., and Kim C.H. A water-extract of the Korean traditional formulation Geiji-Bokryung-Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits. International Immunopharmacology 3 (2003) 723-734
29. Kleiner D.E., and Stetler-Stevenson W.G. Matrix metalloproteinases and metastasis. Cancer Chemotherapy and Pharmacology 43 (1999) 42-51
30. Koo B.S., Kwon T.S., and Kim C.H. Salviae miltiorrhizae radix inhibits superoxide generation by activated rat microglias and mimics the action of amphetamine on in vitro rat striatal dopamine release. Neurochem Research 29 10 (2004) 1837-1845
31. Lay I.S., Chiu J.H., Shiao M.S., Lui W.Y., and Wu C.W. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Medica 69 1 (2003) 26-32
32. Li L.N. Water soluble active components of Salvia miltiorrhiza and related plants. Journal of Chinese Pharmaceutical Science 6 (1997) 57-64
33. Li H.Y., Li Y., Yan C.H., Li L.N., and Chen X.G. Inhibition of tumor growth by S-3-1, a synthetic intermediate of salvianolic acid A. Journal of Asian Natural Products Research 4 4 (2002) 271-280
34. Liu G.T., Zhang T.M., Wang B.E., and Wang Y.W. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochemical Pharmacology 43 (1992) 147-152
35. Liu J., Yang C.F., Lee B.L., Shen H.M., Ang S.G., and Ong C.N. Effect of Salvia miltiorrhiza on aflatoxin B1-induced oxidative stress in cultured rat hepatocytes. Free Radical Research 31 (1999) 559-568
36. Liu P., Hu Y., Liu C., Liu C., and Zhu D. Effects of salviainolic acid A (SA-A) on liver injury: SA-A action on hepatic peroxidation. Liver 21 6 (2001) 384-390
37. Maeda K., Kuzuya M., Cheng X.W., Asai T., Kanda S., Tamaya-Mori N., Sasaki T., Shibata T., and Iguchi A. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis 166 (2003) 23-30
38. Mandal M., Mandal A., Das S., Chakraborti T., and Sajal C. Clinical implications of matrix metalloproteinases. Molecular and Cellular Biochemistry 252 (2003) 305-329
39. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends in Genetics 6 (1990) 121-125
40. Moon S.K., Cho G.O., Jung S.Y., Gal S.W., Kwon T.K., Lee Y.C., Madamanchi N.R., and Kim C.H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cellcycle regulation, and matrix metalloproteinase-9. Biochemical and Biophysical Research Communications 301 (2003) 1069-1078
41. Moon S.K., Cha B.Y., and Kim C.H. In vitro cellular aging is associated with enhanced proliferative capacity, G1 cell cycle modulation, and matrix metalloproteinase-9 regulation in mouse aortic smooth muscle cells. Archives of Biochemistry and Biophysics 418 (2003) 39-48
42. Moon S.K., Cha B.Y., and Kim' C.H. ERK1/2 mediates TNF-α induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: involvement of the Ras dependent pathway. Journal of Cellular Physiology 198 3 (2004) 417-427
43. Mason D.P., Kenagy R.D., Hasenstab D., Bowen-Pope D.F., Seifert R.A., Coats S., Hawkins S.M., and Clowes A.W. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circulation Research 85 (1999) 1179-1185
44. Newby A.C., and Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. Journal of Pathology 190 (2000) 300-309
45. Pauly R.R., Passaniti A., Bilato C., Monticone R., Cheng L., Papadopoulos N., Gluzband Y.A., Smith L., Weinstein C., and Lakatta E.G. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circulation Research 75 (1994) 41-54
46. Ren de C., Du G.H., and Zhang J.T. Inhibitory effect of the water-soluble extract of Salvia miltiorrhiza on neutrophil-endothelial adhesion. Japanese Journal of Pharmacology 90 3 (2002) 276-280
47. Ross R. The pathogenesis of atherosclerosis: an update. New England Journal of Medicine 314 (1986) 488-500
48. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
49. Ross R. Cell biology of atherosclerosis. Annual Review of Physiology 57 (1995) 791-804
50. Sasaguri Y., Murahashi N., Sugama K., Kato S., Hiraoka K., Satoh T., Isomoto H., and Morimatsu M. Development-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Laboratory Investigation 71 (1994) 261-269
51. Schwartz R.S., Holmes D.R., and Topol E.J. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. Journal of the American College of Cardiology 20 (1992) 1284-1293
52. Strauss B.H., Chisholm R.J., Keeley F.W., Gotlieb A.I., Logan R.A., and Armstrong P.W. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circulation Research 75 (1994) 650-658
53. Wang J.M., He H.B., Zhu Y.Q., Shi D.W., Li Y.M., and Zhang Y. Reversed phase HPLC determination of danshensu and protocatechuic aldehyde in Salvia miltiorrhiza. Acta Academy of Medicie at Shanghai vol. 18 (1991) 27-32
54. Woessner Jr. J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB Journal 5 (1991) 2145-2154
55. Wu Y.J., Hong C.Y., Lin S.J., Wu P., and Shiao M.S. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arteriosclerosis, Thrombosis and Vascular Biology 18 3 (1998) 481-486
56. Yagi A., Fujimoto K., Tanonaka K., Hirai K., and Takeo S. Possible active components of tan-shen (Salvia miltiorrhiza) for protection of the myocardium against ischemia-induced derangements. Planta Medica 55 (1989) 51-54
57. Yoshie F., Iizuka A., Kubo M., Komatsu Y., Matsumoto A., Itakura H., Takeda H., Matsumiya T., and Kondo K. Protective effects of Saiko-ka-ryukotsu-borei-to (Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) against atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits. Pharmacological Research 43 (2001) 481-488
58. Zempo N., Koyama N., Kenagy R.D., Lea H.J., and Clowes A.W. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arteriosclerosis, Thrombosis and Vascular Biology 16 (1996) 28-33